Cervical Cancer, Version 2.2026
Cet article présente les recommandations du "National Comprehensive Cancer Network" concernant la prise en charge d'un cancer du col de l'utérus
An estimated 13,360 new cases of carcinoma of the uterine cervix (ie, cervical cancer) will be diagnosed in the United States in 2025, and 4,320 people are estimated to die of the disease1,2 Although cervical cancer rates are decreasing in the United States after the introduction of screening, incidence remains high among Hispanic/Latino, Black, and Asian populations.3–6 The incidence rates of cervical squamous cell carcinoma are highest in Black and Hispanic individuals assigned female at birth (AFAB), while incidence rates of cervical adenocarcinoma are highest among Hispanic and White AFAB individuals.7,8 Overall, cervical cancer is a major world health problem for AFAB individuals. Globally in 2022, there were an estimated 661,021 cervical cancer cases and 348,189 deaths associated with cervical cancer.9,10 It is the fourth most common cancer in AFAB individuals worldwide, with 85% of cases occurring in developing countries where cervical cancer is a leading cause of cancer death in AFAB individuals.1,10–12 It is the most diagnosed cancer in 23 countries and the leading cause of cancer death in 36 countries.13
JNCCN , article en libre accès, 2026